Search results for " industry"
Resource
Advancements in Antibody Purification
Join us November 19 and learn from industry experts on recent advancements and the future of antibody purification.
Article
Reimagining Affordable Biosimilars
Berkowitz, “Biophysical Characterization and its Role in the Biopharmaceutical Industry,” In Biophysical Characterization of Proteins in Developing Biopharmaceuticals, D.J. Houde and S.A. Berkowitz Ed…
Article
Testa Challenge 2020 Attracts Leading International Bioprocessing Innovators
Read more here >>
Six bioprocessing innovators have successfully completed the inaugural Testa Challenge 2020. Held over an intensive week in the Testa Center located at Cytiva´s Uppsala…
Article
Innovations in Cell Culture: Developing the Future
Innovations is a new virtual series from Cytiva exploring the needs of the biopharma industry featuring a panel of Cytiva and external experts.
Explore upcoming events here.
Article
Advancements in Antibody Purification
Join us on November 19, 2020 to learn from industry experts in a panel discussion on recent advancements and the future of antibody purification.
Article
ISPE Releases Cleaning Validation Guide
“This guide provides the requirements, principles, and practices for cleaning validation in a single volume and is the first of its kind in the industry,” said Jose Caraballo, head Audit Program Manag…
Article
Cytiva Introduces the Xcellerex Automated Perfusion System
“Along with our end-to-end flexible manufacturing solutions, automation technology, and trusted expertise, we have introduced Xcellerex APS to support the industry’s journey to integrated continuous m…
Article
Platform for Purification of VHH-type Antibody Fragments
Click here to read this poster >>
Protein A affinity chromatography resins have been used to purify monoclonal antibodies (mAbs) by the bioprocess industry at all scales for a long time. Howev…
Article
Preparing for the Future Visions and Insights for Biomanufacturing
Click here to learn more >>
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targe…
Article
Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need
Click here to read the full article >>
Solid-phase flow through technology poised to annually produce metric tons (1000 kg) provides the oligonucleotide therapeutic industry efficient synthesis t…